Filing Flows

Filing Flows › Technology › Health Catalyst (HCAT)

Health Catalyst (HCAT) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Health Catalyst (HCAT) Q3 2026 earnings results →

Q3 2026 Revenue down 26% year over year to $56.3M · 72¢ of every $1 of revenue kept as net profit · operating margin 89.1%

Health Catalyst made $56.3M in Q3 2026 (-26% Y/Y): Technology $40.7M, Accumulated Impairment Losses $15.6M. Operating margin 89.1%, net earnings $40.5M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.

Revenue$56.3M
Year over year-26%
Operating margin89.1%
Net earnings$40.5M
Operating cash flow−$1.9M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $56.3M in Q3 2026, down 26% year over year and down 20% from the previous quarter. Technology was the largest line at 72% of revenue. Technology lost $11.4M year over year (down 22%), 57% of the total change.

Operating profit was $50.1M, a 89.1% margin (up 112.0 points year over year). Net earnings were $40.5M. The effective tax rate was -1.0%.

Operating cash flow was −$1.9M. Non-cash charges added back $9.7M of depreciation and amortization and $4.1M of share-based compensation. Working capital and other items used $56.2M. Capital expenditures of $156K exceeded it, leaving free cash flow of −$2.0M.

Quarterly history

Health Catalyst revenue by quarterHealth Catalyst revenue by quarter$79.4MQ1 2025$80.7MQ2 2025$76.3MQ3 2025$74.7MQ4 2025$70.8MQ1 2026$70.5MQ2 2026$56.3MQ3 2026
Health Catalyst net earnings by quarterHealth Catalyst net earnings by quarter−$23.7MQ1 2025−$41.0MQ2 2025−$22.2MQ3 2025−$91.0MQ4 2025−$111MQ1 2026−$40.5MQ2 2026$40.5MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 5, 2026$56.3M-26%89.1%$40.5M−$1.9M
Q2 202610-QAug 6, 2026$70.5M-13%-51.8%−$40.5M$275K
Q1 202610-QMay 11, 2026$70.8M-11%-150.5%−$111M$18.5M
Q4 202510-KMar 12, 2026$74.7M-6%-115.3%−$91.0M$9.9M
Q3 202510-QNov 10, 2025$76.3M0%-22.9%−$22.2M−$464K
Q2 202510-QAug 8, 2025$80.7M+6%-46.0%−$41.0M−$9.0M
Q1 202510-QMay 9, 2025$79.4M+6%-25.4%−$23.7M$280K

Charts

Health Catalyst: revenue growth, year over year and quarter over quarterHealth Catalyst: revenue growth, year over year and quarter over quarterY/YQ/Q+6%Q1 2025+6%+2%Q2 20250%-5%Q3 2025-6%-2%Q4 2025-11%-5%Q1 2026-13%0%Q2 2026-26%-20%Q3 2026
Latest (Q3 2026): Y/Y -26%, Q/Q -20%.
Health Catalyst: where the cash came from (+) and went (−), TTM to Q3 2026Health Catalyst: where the cash came from (+) and went (−), TTM to Q3 2026Other financing−$164MOther investing$151MOperating cash flow$26.8MCash drawn (+) / kept (−)−$13.4MCapital spending−$1.1MShares issued$602KAsset & business sales$39KExchange rates−$8K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Health Catalyst: profit against cash, quarter by quarterHealth Catalyst: profit against cash, quarter by quarterNet incomeOperating cash flow−$20.7M−$3.5MQ4 2024−$23.7M$280KQ1 2025−$41.0M−$9.0MQ2 2025−$22.2M−$464KQ3 2025−$91.0M$9.9MQ4 2025−$111M$18.5MQ1 2026−$40.5M$275KQ2 2026$40.5M−$1.9MQ3 2026
Latest (Q3 2026): Net income $40.5M, Operating cash flow −$1.9M.
Health Catalyst: diluted shares by fiscal yearHealth Catalyst: diluted shares by fiscal year40MFY202047MFY202154MFY202256MFY202360MFY202470MFY2025
+76.8% since FY2020: more shares outstanding (issuance, stock pay).
Health Catalyst: long-term debt falling due (FY2025)Health Catalyst: long-term debt falling due (FY2025)$1.6M2026$1.6M2027$1.6M2028$156M2029
Cash $50.8M, short-term investments $44.9M, long-term debt $153M at 2025-12-31.
Health Catalyst in its industry: growth against margin (51 companies, SIC 7370)Health Catalyst in its industry: growth against margin (51 companies, SIC 7370)revenue growth, year over year →↑ operating marginmedian +9%median -1%GOOGLMETASPCXFLUTAPPSNAPZMPINSNIQMTCHSABRTTDRXTFDSTBLATRIPPPLITEMDOCNCSQRTEADEVERBMBLDVMGNIGRNDZIPDSPHSTMNXDRPUBMRUMBLNDCDLXSSTCEVAYYAIPODCIPMGOAIDJTCSAIIPDNCNETTWAVTRSOMITIRMXIGITSBBLRHCAT (-26%, 89%)
Services-Computer Programming, Data Processing, Etc.; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

Customers and suppliers named in filings

Buys from

About Health Catalyst

We are a leading provider of data and analytics technology and services to healthcare organizations. Our Solution comprises our cloud-based data and analytics platform, software applications, and expertise. Our clients, which are primarily healthcare providers, use our Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements. We envision a future where all healthcare decisions are data-informed. Our mission is to be the catalyst for massive, measurable, data-informed healthcare improvement. We fulfill our mission through a confluence of the following elements:

In its own words, from its 10-K, filed Mar 12, 2026.

Health Catalyst against its Services-Computer Programming, Data Processing, Etc. peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -26% against the peers' median +14%. Operating margin: 89.1% against the peers' median 20.1%.

CompanyQuarterRevenueY/YOp. margin
HCAT Health CatalystQ3 2026$56.3M-26%89.1%
GOOGL AlphabetQ3 2026$127.6B+25%31.8%
META Meta PlatformsQ3 2026$64.6B+26%20.1%
SPCX Space Exploration TechnologiesQ3 2026$14.6B+161%19.1%
FLUT Flutter EntertainmentQ3 2026$3.9B+2%-30.7%
APP AppLovinQ3 2026$2.2B+56%78.2%
SNAP SnapQ3 2026$1.7B+14%4.5%
ZM Zoom CommunicationsQ2 FY27$1.3B+5%24.6%
PINS PinterestQ3 2026$1.2B+12%2.6%

Source: Health Catalyst 10-Q on SEC EDGAR · CIK 1636422 · Services-Computer Programming, Data Processing, Etc.

Guidance and outlook

Health Catalyst Revenue: guidance against what was reportedHealth Catalyst Revenue: guidance against what was reportedguided rangereported (above / within / below)FY2026Q2 2026$70.5MQ3 2026$56.3M
Met or beat 2 of 2 guided periods. Grey: the last range guided before the figures came out; dot: the reported figure.
Health Catalyst: what its forward-looking statements are about (10-Q filed 2026-11-05)Health Catalyst: what its forward-looking statements are about (10-Q filed 2026-11-05)Other17Demand11People7Margins5Products3Financing2Deals2Capital spending2Costs2Tax1
53 statements; tone -0.19 (−1 all cautious, +1 all confident); 5 hedged.
Health Catalyst: outlook statements against the filing beforeHealth Catalyst: outlook statements against the filing beforeConfident12Cautious22

13F: who owns HCAT and who is buying

Largest holders of HCAT (13F)Largest holders of HCAT (13F)First Light Asset Management, LLC$25.5MPalogic Value Management, L.P.$19.6MCDC Financial$14.1MVanguard Group$10.6MImpax Asset Management Group$8.0MVanguard Capital Management LLC$5.9MNepsis$5.2MBlackRock$3.7MJane Street Group, LLC$2.1MAMH Equity$1.9M
Funds' net buying of HCAT by quarter (13F)Funds' net buying of HCAT by quarter (13F)$20.2M2024-09−$7.6M2024-12$6.1M2025-03$5.5M2025-06−$828K2025-09−$4.1M2025-12$928K2026-03$3.7M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on HCAT

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare HCAT with

中文版:Health Catalyst(HCAT)财报

Español · Français